Literature DB >> 27007556

AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA.

Bertinellys Teixeira1, Hectorina Rodulfo1, Numirin Carreño1, Militza Guzmán2, Elsa Salazar2, Marcos De Donato1.   

Abstract

The enzymatic modification of aminoglycosides by aminoglycoside-acetyltransferases (AAC), aminoglycoside-adenyltransferases (AAD), and aminoglycoside-phosphotransferases (APH), is the most common resistance mechanism in P. aeruginosa and these enzymes can be coded on mobile genetic elements that contribute to their dispersion. One hundred and thirty seven P. aeruginosa isolates from the University Hospital, Cumana, Venezuela (HUAPA) were evaluated. Antimicrobial susceptibility was determined by the disk diffusion method and theaac, aadB and aph genes were detected by PCR. Most of the P. aeruginosa isolates (33/137) were identified from the Intensive Care Unit (ICU), mainly from discharges (96/137). The frequency of resistant P. aeruginosaisolates was found to be higher for the aminoglycosides tobramycin and amikacin (30.7 and 29.9%, respectively). Phenotype VI, resistant to these antibiotics, was the most frequent (14/49), followed by phenotype I, resistant to all the aminoglycosides tested (12/49). The aac(6´)-Ib,aphA1 and aadB genes were the most frequently detected, and the simultaneous presence of several resistance genes in the same isolate was demonstrated. Aminoglycoside resistance in isolates ofP. aeruginosa at the HUAPA is partly due to the presence of the aac(6´)-Ib, aphA1 andaadB genes, but the high rates of antimicrobial resistance suggest the existence of several mechanisms acting together. This is the first report of aminoglycoside resistance genes in Venezuela and one of the few in Latin America.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27007556      PMCID: PMC4804550          DOI: 10.1590/S1678-9946201658013

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  25 in total

1.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study.

Authors:  Dominique S. Blanc; Christiane Petignat; Béatrice Janin; Jacques Bille; Patrick Francioli
Journal:  Clin Microbiol Infect       Date:  1998-05       Impact factor: 8.067

4.  [Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases].

Authors:  Patricia Q Díaz; Helia T Bello; Mariana Y Domínguez; Natalia F Trabal; Sergio M Mella; Raúl Z Zemelman; Gerardo R González
Journal:  Rev Med Chil       Date:  2004-10       Impact factor: 0.553

5.  [Characterization of the variable region within class 1 integrons in Klebsiella pneumoniae nosocomials strains].

Authors:  Militza Guzmán; Guillermina Alonso
Journal:  Rev Med Chil       Date:  2010-05-19       Impact factor: 0.553

6.  [Susceptibility and resistence of Pseudomonas aeruginosa to antimicrobial agents].

Authors:  M C Gamero Delgado; A D García-Mayorgas; F Rodríguez; A Ibarra; M Casal
Journal:  Rev Esp Quimioter       Date:  2007-06       Impact factor: 1.553

7.  Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.

Authors:  Ja-Young Kim; Yeon-Joon Park; Hi Jeong Kwon; Kyungja Han; Moon Won Kang; Gun-Jo Woo
Journal:  J Antimicrob Chemother       Date:  2008-07-07       Impact factor: 5.790

8.  MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Didier Hocquet; Christelle Vogne; Farid El Garch; Anne Vejux; Naomasa Gotoh; Angela Lee; Olga Lomovskaya; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 9.  Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

Authors:  Tanya Strateva; Daniel Yordanov
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472

10.  Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.

Authors:  Gamal F Gad; Heba A Mohamed; Hossam M Ashour
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

View more
  3 in total

1.  Prevalence and Molecular Typing of Colistin-Resistant Pseudomonas aeruginosa (CRPA) Among β-Lactamase-Producing Isolates: A Study Based on High-Resolution Melting Curve Analysis Method.

Authors:  Hamed Tahmasebi; Sanaz Dehbashi; Mohammad Reza Arabestani
Journal:  Infect Drug Resist       Date:  2020-08-21       Impact factor: 4.003

2.  Phenotypic and genetic properties of susceptible and multidrug-resistant Pseudomonas aeruginosa isolates in Southern Serbia.

Authors:  Marko Milojković; Željka Nenadović; Slaviša Stanković; Dragana D Božić; Nataša Stanković Nedeljković; Ivana Ćirković; Marija Petrović; Ivica Dimkić
Journal:  Arh Hig Rada Toksikol       Date:  2020-10-06       Impact factor: 2.078

3.  Evaluation of phenotypic and genotypic patterns of aminoglycoside resistance in the Gram-negative bacteria isolates collected from pediatric and general hospitals.

Authors:  Leila Azimi; Shahnaz Armin; Hossein Samadi Kafil; Nafiseh Abdollahi; Kiarash Ghazvini; Sepide Hasanzadeh; Shahram Shahraki Zahedani; Sedigheh Rafiei Tabatabaei; Fatemeh Fallah
Journal:  Mol Cell Pediatr       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.